Cardiometabolic Health and Disease in Women: Metabolites and Metabolic Biomarkers
A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Endocrinology and Clinical Metabolic Research".
Deadline for manuscript submissions: closed (15 June 2022) | Viewed by 2661
Special Issue Editors
2. Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
Interests: women's health; cardiovascular diseases; type 2 diabetes; spinal cord injury; clinical epidemiology
Special Issue Information
Dear Colleagues,
Sex differences are described in nearly all human diseases, influencing their prevalence, severity, and prognosis. Cardiometabolic diseases (CMDs) have been taken as a classic example of sexual dimorphism in human diseases. Women are considered to be protected from CMD before menopause. However, this sex advantage for women gradually disappears with increased age, and is associated with reduced estrogen levels after menopause. In addition, other women-specific conditions such as gestational diabetes, preeclampsia and age at menarche have been identified as important determinants of cardiometabolic risk in women throughout the lifespan. Despite the emerging need for tailored women-specific prevention and intervention strategies, our knowledge of sex- and gender-specific markers of CMD remains limited. Metabolomics, the pivotal tool for biomarker discovery, can help us disentangle the underlying mechanisms of disease onset and guide development of women-specific diagnostic and prognostic CMD markers.
This Special Issue, entitled “Cardiometabolic Health and Disease in Women: Metabolites and Metabolic Biomarkers”, highlights the potential of metabolites to be used as biomarkers in clinical and epidemiological research focused on CMD in women. We seek manuscripts focused on understanding the role of women-specific risk factors in the development and prognosis of CMD, the discovery of novel diagnostic and prognostic biomarkers in CMD diseases, and the use of established biomarkers for new indications. In addition, studies focused on sex differences in CMD that contribute to our understanding of women-specific aspects of CMD are eligible. This Special Issue will publish high-quality original research articles (i.e., observational, interventional and experimental studies) and review articles engaging metabolomics approaches to study CMD in women.
Dr. Glisic Marija
Dr. Peter Francis Raguindin
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- women's health
- menopause
- menarche
- preeclampsia
- gestational diabetes
- sex differences
- metabolomics
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
